Working… Menu

An Efficacy and Safety Study of Long-acting Risperidone in Participants With Schizophrenia or Schizoaffective Disorders Who Are Receiving Psychiatric Home Care Treatment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00526877
Recruitment Status : Completed
First Posted : September 10, 2007
Last Update Posted : February 28, 2014
Information provided by (Responsible Party):
Johnson & Johnson Taiwan Ltd

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : January 2009
Actual Study Completion Date : January 2009